FDA

January 23January 23
FDA wants to simplify the use and updating of Covid-19 vaccines
- Coronavirus
The US Food and Drug Administration wants to simplify the Covid-19 vaccine process to look more like what happens with the flu vaccine, according to documents posted online on Monday. That could include streamlining the vaccine composition, immunization schedules and periodic updates of Covid-19 vaccines.

Ceci Partridge
January 02January 02
Sesame joins the major food allergens list, FDA says
- Health
Sesame has joined the list of major food allergens defined by law, according to the US Food and Drug Administration.

Ceci Partridge
October 19October 19
FDA, CDC sign off on Novavax Covid-19 vaccine as a first booster shot
- Coronavirus
Novavax’s Covid-19 vaccine is now available in the United States for use as a first booster dose for people 18 and older.

Ceci Partridge
October 17October 17
A ‘game-changer’ for millions of Americans: You can now buy hearing aids over the counter
- Health
Now, instead of getting a prescription and having a custom fitting with a hearing health professional, adults can buy hearing aids directly from a store or online. Some doctors estimate that 90% of the population with hearing loss could benefit from these over-the-counter devices.

Ceci Partridge
September 29September 29
FDA authorization for updated Covid-19 boosters could be expanded to younger ages as soon as early October
- Coronavirus
- Health
Moderna and Pfizer both sought FDA emergency use authorization for their updated Covid-19 boosters for younger people in recent days. Moderna is seeking authorization for children as young as 6 years and Pfizer for children ages 5 through 11.

Ceci Partridge
September 01September 01
CDC vaccine advisers vote to recommend updated Covid-19 boosters
According to the CDC’s forecasts, boosters given to US adults in September could prevent 137,000 more hospitalizations and 9,700 deaths than if the boosters were held until November.

Ceci Partridge
August 22August 22
FDA authorizes Novavax Covid-19 vaccine for emergency use in ages 12-17
- Health
- National
“One of the things that we believe makes our vaccine unique is that we actually see really good immune response against variants with our prototype vaccine. And so, if you think about the vaccine that we already have authorized that we’re talking about now to be authorized for adolescents, we actually see a good immune response against variants including Omicron, including BA.1 and BA.5,” Taylor said.

Ceci Partridge
May 30
FDA investigating hepatitis A outbreak possibly linked to fresh strawberries
FDA investigating hepatitis A outbreak possibly linked to fresh strawberries.

Tiani Jadulang

Trending Now

Follow us on Facebook

Subscribe